INTELLIGENT BIO SOLUTIONS INC. Operating Cash Flow
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Operating Cash Flow of -$11.93 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.18M.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.33M.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.57M.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.85M.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2026 was -$11.93M.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2025 was -$9.68M.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2024 was -$9.57M.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2023 was -$7.38M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$7.51M derived: sum of 2 quarters · filed 2026-08-19 | -$9.08M derived: sum of 3 quarters · filed 2026-08-19 | -$11.93M 10-K · filed 2026-08-19 |
| 2026-03-31 | -$4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$5.90M derived: sum of 2 quarters · filed 2026-05-13 | -$8.74M 10-Q · filed 2026-05-13 | -$10.95M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$4.41M 10-Q · filed 2026-02-12 | -$6.62M derived: sum of 3 quarters · filed 2026-08-19 | -$9.38M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | -$2.85M 10-Q · filed 2025-11-12 | -$5.06M derived: sum of 2 quarters · filed 2026-08-19 | -$7.81M derived: sum of 3 quarters · filed 2026-08-19 | -$10.14M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$4.97M derived: sum of 2 quarters · filed 2026-08-19 | -$7.29M derived: sum of 3 quarters · filed 2026-08-19 | -$9.68M 10-K · filed 2026-08-19 |
| 2025-03-31 | -$2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$5.08M derived: sum of 2 quarters · filed 2026-05-13 | -$7.47M 10-Q · filed 2026-05-13 | -$10.41M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$4.71M 10-Q · filed 2026-02-12 | -$7.66M derived: sum of 3 quarters · filed 2026-02-12 | -$10.10M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | -$2.39M 10-Q · filed 2025-11-12 | -$5.33M derived: sum of 2 quarters · filed 2025-11-12 | -$7.78M derived: sum of 3 quarters · filed 2025-11-12 | -$10.65M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | -$5.39M derived: sum of 2 quarters · filed 2025-08-15 | -$8.26M derived: sum of 3 quarters · filed 2025-08-15 | -$9.57M 10-K · filed 2025-08-15 |
| 2024-03-31 | -$2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$5.32M derived: sum of 2 quarters · filed 2025-05-13 | -$6.63M 10-Q · filed 2025-05-13 | -$7.21M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$4.18M 10-Q · filed 2025-02-13 | -$4.77M derived: sum of 3 quarters · filed 2025-02-13 | -$7.28M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | -$1.31M 10-Q · filed 2024-11-07 | -$1.90M derived: sum of 2 quarters · filed 2024-11-07 | -$4.41M derived: sum of 3 quarters · filed 2024-11-07 | -$6.80M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$584.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | -$3.10M derived: sum of 2 quarters · filed 2024-09-18 | -$5.48M derived: sum of 3 quarters · filed 2024-09-18 | -$7.38M 10-K · filed 2024-09-18 |
| 2023-03-31 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | -$4.90M derived: sum of 2 quarters · filed 2024-05-08 | -$6.79M 10-Q · filed 2024-05-08 | -$8.52M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | -$4.27M 10-Q · filed 2024-02-09 | -$6.00M derived: sum of 3 quarters · filed 2024-02-09 | -$6.29M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-09-30 | -$1.89M 10-Q · filed 2023-11-08 | -$3.62M derived: sum of 2 quarters · filed 2023-11-08 | -$3.91M derived: sum of 3 quarters · filed 2023-11-08 | -$5.33M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$2.02M derived: sum of 2 quarters · filed 2023-08-23 | -$3.44M derived: sum of 3 quarters · filed 2023-08-23 | -$3.36M 10-K · filed 2023-08-23 |
| 2022-03-31 | -$292.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$1.72M derived: sum of 2 quarters · filed 2023-05-11 | -$1.63M 10-Q · filed 2023-05-11 | -$3.32M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$1.34M 10-Q · filed 2023-02-14 | -$3.03M derived: sum of 3 quarters · filed 2023-02-14 | -$9.18M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $82.96K 10-Q · filed 2022-11-14 | -$1.60M derived: sum of 2 quarters · filed 2022-11-14 | -$7.76M derived: sum of 3 quarters · filed 2022-11-14 | -$8.54M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | -$7.84M derived: sum of 2 quarters · filed 2022-09-22 | -$8.62M derived: sum of 3 quarters · filed 2022-09-22 | -$11.30M 10-K · filed 2022-09-22 |
| 2021-03-31 | -$6.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$6.94M derived: sum of 2 quarters · filed 2022-05-16 | -$9.61M 10-Q · filed 2022-05-16 | -$9.42M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$776.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | -$3.45M 10-Q · filed 2022-02-11 | -$3.26M derived: sum of 3 quarters · filed 2022-02-11 | -$3.48M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | -$2.68M 10-Q · filed 2021-11-12 | -$2.48M derived: sum of 2 quarters · filed 2021-11-12 | -$2.70M derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-30 | $194.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | -$23.68K derived: sum of 2 quarters · filed 2021-09-16 | -$498.62K 10-K · filed 2021-09-16 | |
| 2020-03-31 | -$218.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | -$693.59K 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | -$474.94K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |